The Immunity Study

The Immunity Study is exploring a new potential treatment for autoimmune diseases. These conditions, such as Rheumatoid Arthritis and Type 1 Diabetes, occur when the immune system mistakenly attacks the body’s own tissues.

The study drug, administered via an oral tablet, aims to provide an effective new treatment option for people with autoimmune conditions.

This study is important because there is currently a lack of effective treatment options for autoimmune diseases. We hope this study will be the first step in providing a new, safe, and successful form of treatment for these conditions.

The trial has been approved by an independent ethics committee, and eligible participants will be reimbursed for their time.

Call us at 1800 243 733 to discuss your eligibility today!